Navigation Links
Cypak Compliancy Connection Powers Stora Enso Pharma DDSi
Date:11/20/2007

STOCKHOLM, November 20 /PRNewswire/ -- Stora Enso, a leading producer of pharmaceutical packaging boards, has launched Pharma DDSi , the first intelligent pharmaceutical packaging solution to use Cypak's Compliancy Connection.

Compliancy Connection is a standard low-cost electronic module built around a single RFID microchip and is designed to be embedded in pharmaceutical packaging. Electronic sensors are printed onto the packaging to detect when a dose of medicine is removed.

Non-compliance is increasingly recognized as a major problem in health care. Experts believe that over 50% of people do not take their medication as prescribed, causing tens of thousands of avoidable admissions to hospitals and care homes.

There are many reasons for non-compliancy. Memory lapses result in people skipping a dose or even taking multiple doses. Some people worry about side-effects, others misinterpret the instructions on how to take the medication. Sometimes children take medicines that are not intended for them, and older people struggle to open the packaging. Lack of objective compliancy data may even cause doctors to switch medication or increase dosage levels unnecessarily.

Pharma DDSi is a holistic solution that improves compliancy, providing objective data to caregivers and patients alike:

- Electronics embedded in the package provide reminders, record medication events, and transmit the medication history to the care-giver.

- A printed questionnaire captures the patient's feelings when taking medication. Direct communication to a specialist warns of side-effects and enables early intervention.

- DDSi is a carton solution. Clear instructions for use are printed on the packaging.

- Stora Enso also offers child resistant and senior friendly packaging solutions.

Pharma DDSi works with a variety of database solutions including PackAgent Compliance Monitoring software. This system is used for tracking and tracing the packages, capturing the compliance data and sharing results.

Per Nathanaelson, Cypak CEO, comments: "The low-cost electronic solution provided by Cypak, combined with Stora Enso's expertise, is further opening the way for widespread global adoption of intelligent pharmaceutical packaging."

Ismo Saarinen, Director, Pharmaceutical Solutions, Stora Enso, comments: "Pharma DDSi is a ground breaking solution. Together with Cypak we will continue to drive innovation, affordability, and connectivity."

Links: http://www.cypak.com and http://www.storaenso.com/pharma


'/>"/>
SOURCE Cypak AB
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. NIH awards $10.8M to Columbia to study connection between diabetes and heart disease
3. Vitasoy Promotes the Soy Breast Health Connection
4. Randy Jackson and the American Heart Association Promote Awareness about the Connection Between Type 2 Diabetes and Cardiovascular Disease
5. Research examines connection between substance abuse and violence
6. Bestselling Author Dr. Timothy Brantley Explains the Connection of Food and Mood
7. Study finds no connection between vitamin D and overall cancer deaths
8. Free Seminar Features State Funds Back Connection(TM), November 14, in Chico
9. Free Seminar Presents State Funds Back Connection(TM), November 13, in Redding
10. Hormonal Changes and Depression: What is the Connection?
11. Health Knowledge Empowers the Public
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
Breaking Medicine Technology: